Sort   by:  
 Page size 
UnknownEvaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab.
Not available
S-EPMC5070547 | biostudies-literature
UnknownProgrammed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.
Not available
S-EPMC5562434 | biostudies-literature
UnknownFive-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Not available
S-EPMC6503622 | biostudies-literature
UnknownBaseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Not available
S-EPMC6916264 | biostudies-literature
Sort   by:  
 Page size